Literature DB >> 8036296

Lobar atelectasis in cystic fibrosis and treatment with recombinant human DNase I.

P L Shah1, S F Scott, M E Hodson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8036296     DOI： 10.1016/0954-6111(94)90063-9

Source DB:  PubMed          Journal:  Respir Med        ISSN： 0954-6111            Impact factor:   3.415


× No keyword cloud information.
  4 in total

Review 1.  Progressive unilateral lung collapse in cystic fibrosis--a therapeutic challenge.

Authors:  William G Flight; Janet Hildage; A Kevin Webb
Journal:  J R Soc Med       Date:  2012-06       Impact factor: 5.344

2.  Recombinant human DNase in management of lobar atelectasis due to retained secretions.

Authors:  B A Touleimat; C S Conoscenti; J M Fine
Journal:  Thorax       Date:  1995-12       Impact factor: 9.139

Review 3.  Is bronchoscopy an obsolete tool in cystic fibrosis? The role of bronchoscopy in cystic fibrosis and its clinical use.

Authors:  Lisa Paul
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

Review 4.  Dornase alfa. A review of its pharmacological properties and therapeutic potential in cystic fibrosis.

Authors:  H M Bryson; E M Sorkin
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.